BALAXI PHARMACEUTICALS bulk deals, insider trading and stake changes
NSE: BALAXIPharmaceuticals & BiotechnologySmall Cap
BALAXI PHARMACEUTICALS LIMITED · Formerly Balaxi Ventures · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2015
Last close ₹19.71down ₹0.62 (3.05%)
Share price at the NSE close on 29 Oct 2026. Previous close ₹20.33.
29 Oct: open ₹20.60, high ₹20.60, low ₹19.16
52-week range of traded prices to 29 Oct 2026
₹15.20Low, 27 Mar 2026₹43.85High, 4 Nov 2025
- Next results date: the board meets on 12 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹109 Cr2,722nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.88
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 31,01671.2% delivered
BALAXI PHARMACEUTICALS' insiders have 45 trade disclosures on record, the latest on 2 Feb 2025. Its promoter group made no purchase or sale on the market in the 12 months to 29 Oct 2026.
BALAXI PHARMACEUTICALS insider trading
The company's own latest disclosure on record is from Apr 2024.Insider trading, all companies
Sep 2024
- AMOL ANAND MANTRI₹0.33 Cr27,000 sharesSold or invoked · Designated Person · 16 Sep 2024 · disclosed 2 Feb 2025
- AMOL ANAND MANTRI₹0.02 Cr2,000 sharesSold or invoked · Designated Person · 12 Sep 2024 · disclosed 2 Feb 2025
Aug 2024
- AMOL ANAND MANTRI₹0.19 Cr16,236 sharesSold or invoked · Designated Person · 23 Aug 2024 · disclosed 2 Feb 2025
Jun 2024
- AMOL ANAND MANTRI₹0.04 Cr3,037 sharesSold or invoked · Designated Person · 27 Jun 2024 · disclosed 1 Jul
- AMOL ANAND MANTRI₹0.12 Cr9,735 sharesSold or invoked · Designated Person · 26 Jun 2024 · disclosed 28 Jun
- AMOL ANAND MANTRI₹0.26 Cr20,592 sharesSold or invoked · Designated Person · 20 Jun 2024 · disclosed 27 Jun
May 2024
- SplitEach share became 5 on 30 May 2024. The lines below are on the share count before it.
- KUNAL MAHENDRA BHAKTA₹3.00 Cr50,000 sharesBought · Designated Person · 6 May 2024 · disclosed 8 May
Apr 2024
- MANGINA SRINIVAS RAO₹0.29 Cr5,000 sharesBought · Designated Person · 19 Apr 2024 · disclosed 23 Apr
- KUNAL MAHENDRA BHAKTA₹0.93 Cr16,000 sharesBought · Designated Person · 19 Apr 2024 · disclosed 23 Apr
- KUNAL MAHENDRA BHAKTA₹1.69 Cr50,000 sharesReceived · Director · 11 Apr 2024 · disclosed 12 Apr · Conversion of security · stake 1.43% before, 1.86% after
- KUNAL MAHENDRA BHAKTA₹1.69 Cr50,000 unitsGave · Director · 11 Apr 2024 · Warrants · disclosed 12 Apr · Conversion of security · held 50,000 before
Mar 2024
- KUNAL MAHENDRA BHAKTA₹3.28 Cr67,000 sharesBought · Designated Person · 28 Mar 2024 · disclosed 4 Apr
- MANGINA SRINIVAS RAO₹0.17 Cr5,000 sharesReceived · Director · 15 Mar 2024 · disclosed 18 Mar · Conversion of security · stake 0.04% before, 0.09% after
- MANGINA SRINIVAS RAO₹0.17 Cr5,000 unitsGave · Director · 15 Mar 2024 · Warrants · disclosed 18 Mar · Conversion of security · held 5,000 before
- KUNAL MAHENDRA BHAKTA₹0.54 Cr16,000 sharesReceived · Director · 15 Mar 2024 · disclosed 18 Mar · Conversion of security · stake 1.30% before, 1.43% after
- KUNAL MAHENDRA BHAKTA₹0.54 Cr16,000 unitsGave · Director · 15 Mar 2024 · Warrants · disclosed 18 Mar · Conversion of security · held 66,000 before, holds 50,000 after
Feb 2024
3 entries
- KUNAL MAHENDRA BHAKTA₹4.14 Cr67,000 sharesBought · Designated Person · 29 Feb 2024 · disclosed 15 Mar
- KUNAL MAHENDRA BHAKTA₹2.27 Cr67,000 sharesReceived · Director · 23 Feb 2024 · disclosed 26 Feb · Conversion of security · held 72,771 before, holds 1,39,771 after, stake 1.30% after
- KUNAL MAHENDRA BHAKTA₹2.27 Cr67,000 unitsGave · Director · 23 Feb 2024 · Warrants · disclosed 26 Feb · Conversion of security · held 1,33,000 before, holds 66,000 after
Jan 2024
2 entries
- KUNAL MAHENDRA BHAKTA₹2.27 Cr67,000 sharesReceived · Director · 25 Jan 2024 · disclosed 26 Jan · Conversion of security · stake 0.06% before, 0.70% after
- KUNAL MAHENDRA BHAKTA₹2.27 Cr67,000 unitsGave · Director · 25 Jan 2024 · Warrants · disclosed 26 Jan · Conversion of security · held 2,00,000 before, holds 1,33,000 after
Mar 2023
1 entry
- MANGINA SRINIVAS RAO₹0.27 Cr5,000 sharesBought · Designated Person · 2 Mar 2023 · disclosed 16 Mar
Jan 2023
2 entries
- MANGINA SRINIVAS RAO₹0.17 Cr5,000 unitsGave · Director · 27 Jan 2023 · Warrants · disclosed 30 Jan · Conversion of security · held 10,000 before, holds 5,000 after
- MANGINA SRINIVAS RAO₹0.17 Cr5,000 sharesReceived · Director · 27 Jan 2023 · disclosed 30 Jan · Conversion of security · holds 5,000 after, stake 0.04% after
Dec 2022
2 entries
- KUNAL MAHENDRA BHAKTA₹0.27 Cr4,605 sharesSold or invoked · Designated Person · 6 Dec 2022 · disclosed 26 Dec
- KUNAL MAHENDRA BHAKTA₹0.27 Cr4,605 sharesBought · Designated Person · 6 Dec 2022 · disclosed 26 Dec
Oct 2022
3 entries
- MANGINA SRINIVAS RAO₹0.11 Cr10,000 unitsReceived · Director · 11 Oct 2022 · Warrants · disclosed 13 Oct · Preferential Offer · holds 10,000 after
- KUNAL MAHENDRA BHAKTA₹2.26 Cr2,00,000 unitsReceived · Director · 11 Oct 2022 · Warrants · disclosed 12 Oct · Preferential Offer · holds 2,00,000 after
- KUNAL MAHENDRA BHAKTA0sharesReceived · Director · 11 Oct 2022 · disclosed 12 Oct · Preferential Offer · stake 0.05% before, 0.05% after
Sep 2022
2 entries
- KUNAL MAHENDRA BHAKTA₹0.26 Cr4,605 sharesBought · Designated Person · 5 Sep 2022 · disclosed 22 Sep
- KUNAL MAHENDRA BHAKTA₹0.26 Cr4,605 sharesSold or invoked · Designated Person · 5 Sep 2022 · disclosed 22 Sep
Feb 2021
4 entries
- KUNAL MAHENDRA BHAKTA₹0.14 Cr2,302 sharesBought · Director · 12 Feb 2021 · disclosed 9 Mar · held 2,297 before, holds 4,599 after
- KUNAL MAHENDRA BHAKTA₹0.09 Cr1,440 sharesBought · Designated Person · 11 Feb 2021 · disclosed 22 Mar
- KUNAL MAHENDRA BHAKTA₹0.13 Cr2,097 sharesBought · Designated Person · 4 Feb 2021 · disclosed 22 Mar
- KUNAL MAHENDRA BHAKTA₹0.14 Cr2,297 sharesBought · Director · 4 Feb 2021 · disclosed 12 Feb · holds 2,297 after
Jan 2021
1 entry
- AMOL ANAND MANTRI₹0.33 Cr5,600 sharesSold · Employees/Designated Employees · 25 Jan 2021 · disclosed 5 Mar · held 1,79,065 before, holds 1,73,465 after
Aug 2020
2 entries
- AMOL ANAND MANTRI₹0.90 Cr31,460 sharesSold · Employees/Designated Employees · 5 Aug 2020 · disclosed 7 Aug · held 2,10,525 before, holds 1,79,065 after
- AMOL ANAND MANTRI₹4.62 Cr1,78,450 sharesSold · Employees/Designated Employees · 3 Aug 2020 · disclosed 4 Aug · held 3,88,975 before, holds 2,10,525 after
Jun 2020
1 entry
- AMOL ANAND MANTRI₹0.14 Cr11,525 sharesSold · Employees/Designated Employees · 19 Jun 2020 · disclosed 29 Jun · held 4,00,500 before, holds 3,88,975 after
Aug 2019
2 entries
- BALAXI OVERSEAS PVT LTD₹13 Cr49,99,964 sharesReceived · Promoters · 9 Aug 2019 · Preferential Offer · held 20,00,036 before, holds 70,00,000 after
- ASHISH MAHESHWARI₹0.16 Cr60,036 sharesReceived · Promoter Group · 9 Aug 2019 · Preferential Offer · held 1,20,738 before, holds 1,80,774 after
Jun 2017
1 entry
- BALAXI OVERSEAS PVT LTD₹0.50 Cr3,30,000 sharesReceived · Promoters · 29 Jun 2017 · disclosed 1 Jul · Others · held 16,70,036 before, holds 20,00,036 after
May 2017
3 entries
- BALAXI OVERSEAS PVT LTD₹1.80 Cr12,00,000 sharesReceived · Promoters · 19 May 2017 · Off Market · held 4,70,036 before, holds 16,70,036 after
- NIREJ V PAUL₹0.46 Cr3,07,510 sharesGave · Promoters · 4 May 2017 · disclosed 5 May · Off Market · held 6,07,510 before, holds 3,00,000 after
- BALAXI OVERSEAS PVT LTD₹0.71 Cr4,70,036 sharesReceived · Promoters · 4 May 2017 · disclosed 5 May · Off Market · holds 4,70,036 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
BALAXI PHARMACEUTICALS stake sales and purchases
All 12 disclosures on record.
Jun 2025
- SoldEBISU Global Opportunities Fund Limited0.91% of the company5,00,000 sharesholds 4.85% after3 Jun 2025 · filed under the 2% rule · Open Market
Apr 2025
- SoldEBISU Global Opportunities Fund Limited2.44% of the company13,45,891 sharesholds 5.75% after24 Apr 2025 · filed under the 2% rule · Open Market
- SoldUNICO GLOBAL OPPORTUNITIES FUND LIMITED8.29% of the company45,77,717 sharesholds none after3 Apr 2025 · filed under the 2% rule · Open Market
Mar 2025
- AcquiredEBISU Global Opportunities Fund Limited8.18% of the company45,21,028 sharesholds 8.18% after3 Mar 2025 · filed under the 5% rule · Open Market
- SoldMGC Fund Limited9.50% of the company46,50,000 sharesholds none after3 Mar 2025 · filed under the 2% rule
- SoldELARA INDIA OPPORTUNITIES FUND LIMITED9.50% of the company47,05,248 sharesholds none after3 Mar 2025 · filed under the 2% rule
May 2024
- SplitEach share became 5 on 30 May 2024. The lines below are on the share count before it.
Aug 2019
- AcquiredMarshal Global Capital Fund Limited9.50% of the company9,50,000 sharesholds 31.25% after9 Aug 2019 · filed under the 5% rule · Preferential Allotment
- AcquiredElara India opportunities Fund Ltd9.50% of the company9,50,000 sharesholds 9.50% after9 Aug 2019 · filed under the 5% rule · Preferential Allotment
- DisclosedAmol Anand Mantriholds 4.01% after9 Aug 2019 · filed under the 2% rule
- AcquiredBalaxi Overseas Private Ltd · promoter4.21% of the company49,99,964 sharesholds 70.00% after9 Aug 2019 · filed under the 2% rule · Preferential Allotment
- AcquiredMrs. Minoshi Maheshwari · promoter2.42% of the companyholds 1.05% after9 Aug 2019 · filed under the 2% rule · Preferential Allotment
- AcquiredMr. Ashish Maheshwari · promoter2.16% of the company60,036 sharesholds 1.81% after9 Aug 2019 · filed under the 2% rule · Preferential Allotment
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
BALAXI PHARMACEUTICALS bulk deals
Last 12 months, since 29 Oct 2025: 5 bulk deals, ₹4.39 Cr bought and ₹1.05 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 24 Mar 20261 firm · ₹0.92 Cr bought · ₹0 soldNet bought ₹0.92 Cr
- BoughtRGSL INVESTMENT LVF 1Bought 5,22,340 at ₹17.680.95% of the company₹0.92 Cr
Monday 23 Mar 20261 firm · ₹0.90 Cr bought · ₹0 soldNet bought ₹0.90 Cr
- BoughtRGSL INVESTMENT LVF 1Bought 5,20,197 at ₹17.240.94% of the company₹0.90 Cr
Wednesday 31 Dec 20251 firm · ₹1.16 Cr bought · ₹0 soldNet bought ₹1.16 Cr
- BoughtMITHUN KHAITANBought 4,20,000 at ₹27.620.76% of the company₹1.16 Cr
Friday 12 Dec 20251 firm · ₹1.41 Cr bought · ₹1.05 Cr soldNet bought ₹0.36 Cr
- Both waysDULCET ADVISORY PRIVATE LIMITEDBought 4,71,000 at ₹30.00Sold 3,30,564 at ₹31.820.85% of the companyNet +1,40,436 shares₹1.41 Cr bought
Thursday 10 Jul 20251 firm · ₹1.46 Cr bought · ₹0.02 Cr soldNet bought ₹1.44 Cr
- Both waysDULCET ADVISORY PRIVATE LIMITEDBought 2,91,943 at ₹50.02Sold 4,943 at ₹50.320.53% of the companyNet +2,87,000 shares₹1.46 Cr bought
Tuesday 1 Jul 20251 firm · ₹1.60 Cr bought · ₹0 soldNet bought ₹1.60 Cr
- BoughtDULCET ADVISORY PRIVATE LIMITEDBought 3,20,000 at ₹50.000.58% of the company₹1.60 Cr
Friday 4 Apr 20251 firm · ₹0 bought · ₹2.01 Cr soldNet sold ₹2.01 Cr
- SoldEBISU GLOBAL OPPORTUNITIES FUND LIMITEDSold 2,98,446 at ₹67.500.54% of the company₹2.01 Cr
Thursday 3 Apr 20254 firms · ₹28 Cr bought · ₹29 Cr soldNet sold ₹1.05 Cr
- SoldUNICO GLOBAL OPPORTUNITIES FUND LIMITEDSold 41,27,717 at ₹68.007.48% of the company₹28 Cr
- BoughtNEXPACT LIMITEDBought 25,00,000 at ₹68.004.53% of the company₹17 Cr
- BoughtMULTITUDE GROWTH FUNDS LIMITEDBought 13,00,000 at ₹68.002.35% of the company₹8.84 Cr
- Both waysPADMAVATI HOLDINGS PVT LTDBought 2,77,000 at ₹68.00Sold 1,00,000 at ₹70.020.50% of the companyNet +1,77,000 shares₹1.88 Cr bought
Wednesday 2 Apr 20252 firms · ₹3.03 Cr bought · ₹3.02 Cr soldNet bought ₹0.01 Cr
- BoughtSHRISTI INVESTMENTS PRIVATE LIMITEDBought 4,51,953 at ₹67.000.82% of the company₹3.03 Cr
- SoldUNICO GLOBAL OPPORTUNITIES FUND LIMITEDSold 4,50,000 at ₹67.000.82% of the company₹3.02 Cr
Monday 3 Mar 20254 firms · ₹48 Cr bought · ₹48 Cr soldNet nil
- SoldELARA INDIA OPPORTUNITIES FUND LIMITEDSold 45,77,717 at ₹53.008.29% of the company₹24 Cr
- BoughtUNICO GLOBAL OPPORTUNITIES FUND LIMITEDBought 45,77,717 at ₹53.008.29% of the company₹24 Cr
- BoughtEBISU GLOBAL OPPORTUNITIES FUND LIMITEDBought 45,21,028 at ₹53.008.19% of the company₹24 Cr
- SoldMGC FUND LIMITEDSold 45,21,028 at ₹53.008.19% of the company₹24 Cr
SplitEach share became 5 on 30 May 2024. The lines below are on the share count before it.
Monday 3 Aug 20201 firm · ₹0 bought · ₹4.62 Cr soldNet sold ₹4.62 Cr
- SoldAMOL ANAND MANTRISold 1,78,450 at ₹259.051.78% of the company₹4.62 Cr
Tuesday 30 Apr 20191 firm · ₹0 bought · ₹0.19 Cr soldNet sold ₹0.19 Cr
- SoldALAGAPPAN V.Sold 20,000 at ₹94.830.66% of the company₹0.19 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 20 deals on record since listing on 30 Nov 2015.